310 related articles for article (PubMed ID: 29935131)
1. Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria.
Nwokolo E; Ujuju C; Anyanti J; Isiguzo C; Udoye I; BongosIkwue E; Ezire O; Raji M; Oyibo WA
Int J Health Policy Manag; 2018 Jun; 7(6):542-548. PubMed ID: 29935131
[TBL] [Abstract][Full Text] [Related]
2. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
Ladner J; Davis B; Audureau E; Saba J
Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
[TBL] [Abstract][Full Text] [Related]
3. Presumptive treatment of malaria from formal and informal drug vendors in Nigeria.
Isiguzo C; Anyanti J; Ujuju C; Nwokolo E; De La Cruz A; Schatzkin E; Modrek S; Montagu D; Liu J
PLoS One; 2014; 9(10):e110361. PubMed ID: 25333909
[TBL] [Abstract][Full Text] [Related]
4. Malaria testing and treatment knowledge among selected rural patent and proprietary medicine vendors (PPMV) in Nigeria.
Oladepo O; Oyeyemi AS; Titiloye MA; Adeyemi AO; Burnett SM; Apera I; Oladunni O; Alliu M
Malar J; 2019 Mar; 18(1):103. PubMed ID: 30917835
[TBL] [Abstract][Full Text] [Related]
5. The private sector market for malaria rapid diagnostic tests in Nigeria: results of the 2018 market survey.
Edwards HM; Sarwar R; Mahmud P; Emmanuel S; Maxwell K; Tibenderana JK
Malar J; 2022 Jun; 21(1):190. PubMed ID: 35710474
[TBL] [Abstract][Full Text] [Related]
6. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H
BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199
[TBL] [Abstract][Full Text] [Related]
7. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy.
Ezenduka CC; Ogbonna BO; Ekwunife OI; Okonta MJ; Esimone CO
Malar J; 2014 Jun; 13():243. PubMed ID: 24961280
[TBL] [Abstract][Full Text] [Related]
8. Adherence to malaria diagnosis and treatment guidelines among healthcare workers in Ogun State, Nigeria.
Bamiselu OF; Ajayi I; Fawole O; Dairo D; Ajumobi O; Oladimeji A; Steven Y
BMC Public Health; 2016 Aug; 16(1):828. PubMed ID: 27538947
[TBL] [Abstract][Full Text] [Related]
9. Progress toward elimination of malaria in Nigeria: uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City.
Akoria OA; Arhuidese IJ
Ann Afr Med; 2014; 13(3):104-13. PubMed ID: 24923369
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.
Briggs MA; Kalolella A; Bruxvoort K; Wiegand R; Lopez G; Festo C; Lyaruu P; Kenani M; Abdulla S; Goodman C; Kachur SP
PLoS One; 2014; 9(4):e94074. PubMed ID: 24732258
[TBL] [Abstract][Full Text] [Related]
11. Private sector antimalarial sales a decade after "test and treat": A cross-sectional study of drug shop clients in rural Uganda.
Shelus V; Mumbere N; Mulogo EM; Barrington C; Baguma E; Muhindo R; Herrington JE; Emch M; Maman S; Boyce RM
Front Public Health; 2023; 11():1140405. PubMed ID: 37056663
[TBL] [Abstract][Full Text] [Related]
12. Incentivizing appropriate malaria case management in the private sector: a study protocol for two linked cluster randomized controlled trials to evaluate provider- and client-focused interventions in western Kenya and Lagos, Nigeria.
Woolsey AM; Simmons RA; Woldeghebriel M; Zhou Y; Ogunsola O; Laing S; Olaleye T; Kipkoech J; Rojas BM; Saran I; Odhiambo M; Malinga J; Ambani G; Kimachas E; Fashanu C; Wiwa O; Menya D; Laktabai J; Visser T; Turner EL; O'Meara WP
Implement Sci; 2021 Jan; 16(1):14. PubMed ID: 33472650
[TBL] [Abstract][Full Text] [Related]
13. The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveys.
Edwards HM; Sarwar R; Mahmud P; Emmanuel S; Maxwell K; Tibenderana JK
Malar J; 2022 Feb; 21(1):42. PubMed ID: 35151332
[TBL] [Abstract][Full Text] [Related]
14. Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda.
Woldeghebriel M; Aso E; Berlin E; Fashanu C; Kirumira SN; Lam F; Mugerwa R; Nakiganda J; Olaleye T; Opigo J; Osinupebi F; Priestley N; Stringham R; Uhomoibhi P; Visser T; Ward A; Wiwa O; Woolsey A
Malar J; 2024 Feb; 23(1):41. PubMed ID: 38321459
[TBL] [Abstract][Full Text] [Related]
15. Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.
Prudhomme O'Meara W; Menya D; Laktabai J; Platt A; Saran I; Maffioli E; Kipkoech J; Mohanan M; Turner EL
PLoS Med; 2018 Jul; 15(7):e1002607. PubMed ID: 30016316
[TBL] [Abstract][Full Text] [Related]
16. Differences in malaria care seeking and dispensing outcomes for adults and children attending drug vendors in Nasarawa, Nigeria.
Liu J; Isiguzo C; Sieverding M
Trop Med Int Health; 2015 Aug; 20(8):1081-92. PubMed ID: 25877471
[TBL] [Abstract][Full Text] [Related]
17. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries.
Littrell M; Gatakaa H; Evance I; Poyer S; Njogu J; Solomon T; Munroe E; Chapman S; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Shewchuk T; Chavasse D; O'Connell KA
Malar J; 2011 Oct; 10():327. PubMed ID: 22039892
[TBL] [Abstract][Full Text] [Related]
18. Factors impacting test-based management of suspected malaria among caregivers of febrile children and private medicine retailers within rural communities of Fanteakwa North District, Ghana.
Soniran OT; Abuaku B; Anang A; Opoku-Afriyie P; Ahorlu C
BMC Public Health; 2021 Oct; 21(1):1899. PubMed ID: 34666733
[TBL] [Abstract][Full Text] [Related]
19. Stocking pattern for anti-malarial medications among proprietary patent medicine vendors in Akinyele Local Government Area, Ibadan, Nigeria.
Kodaolu MY; Fagbamigbe AF; Ajayi IO
Malar J; 2020 Aug; 19(1):279. PubMed ID: 32746914
[TBL] [Abstract][Full Text] [Related]
20. Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.
Maloney K; Ward A; Krenz B; Petty N; Bryson L; Dolkart C; Visser T; Le Menach A; Scott VK; Cohen JM; Mtumbuka E; Mkude S
Malar J; 2017 Jan; 16(1):6. PubMed ID: 28049481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
